Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Gallucci RM, Sloan DK, Heck DE, Laskin JD
6 Limitations and future directions The above studies discussed the effects of SSRIs in the reproductive system, but the following limitations exist: the small sample sizes of several studies and the lack of large-scale, multicenter, randomized controlled trials
NADPH oxidase regulates Paraquat and maneb-induced dopaminergic neurodegeneration through ferroptosis
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
US$ 25.06
US$ 25.05
US$ 27.58
US$ 23.50
US$ 29.97
US$ 22.58
US$ 21.43
